Drug resistance of secondary acute myeloid leukemia with megakaryoblastic features and p190 BCR-ABL rearrangement

Leukemia Research

Volumn 22, Issue 11, 1998, Pages 1021-1027

  Veelken, Hendrik ^a   Licht, Thomas ^b   Lais, Angela ^a   Köhler, Gabriele ^a   Mertelsmann, Roland ^a   Schaefer, Hans Eckart ^a   Lübbert, Michael ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Acute myeloid leukemia; Alkylating agents; Autologous bone marrow transplantation; Megakaryoblast; P glycoprotein; Philadelphia chromosome

Indexed keywords

ALKYLATING AGENT; BCR ABL PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; AUTOPSY; BLAST CELL CRISIS; CANCER REGRESSION; CASE REPORT; DRUG RESISTANCE; FEMALE; GENE OVEREXPRESSION; GENE REARRANGEMENT; HUMAN; MEGAKARYOBLAST; MULTIPLE MYELOMA; NEUTROPENIA; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

DRUG RESISTANCE, NEOPLASM; FEMALE; FUSION PROTEINS, BCR-ABL; HUMANS; LEUKEMIA, MEGAKARYOCYTIC, ACUTE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASMS, SECOND PRIMARY; P-GLYCOPROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0031693678     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(98)00089-7     Document Type: Article

References (28)

1. Levine EG, Bloomfield CD Secondary myelodysplastic syndromes and leukemias. Clin Haematol. 15:1986;1037.
2. Peterson BA, Levine EG Uncommon subtypes of acute nonlymphocytic leukemia: clinical features and management of FAB M5, M6 and M7. Semin Oncol. 14:1987;425.
3. Schaefer HE Histological processing of iliac crest biopsies based on decalcification and paraffin embedding with reference to osteolytic and hematologic diagnosis. Pathologe. 16:1995;11.
4. Maurer J, Kinzel H, Nentwig T, Thiel R Molecular diagnosis of the Philadelphia chromosome in chronic myelogenous and acute lymphoblastic leukemias by PCR. Disease Markers. 8:1990;211.
5. Licht T, Lübbert M, Martens C, Herrman F, Mertelsmann R Tumor necrosis factor-α and interleukin-6 induce MDR1 (multidrug-resistance) gene expression in pleural mesothelioma cells. Onkologie. 17:1994;90a.
6. Akiyama SI, Fojo A, Hanover JA, Pastan I, Gottesman MM Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somatic Cell Mol Genet. 11:1985;117.
7. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, Pirker R, Green A, Crist W, Brodeur GMet al. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst. 81:1989;116.
8. Licht T, Fiebig HH, Bross KJ, Herrmann F, Berger DP, Shoenaker R, Mertelsmann R Induction of multiple-drug resistance during anti-neoplastic chemotherapy in vitro. Int J Cancer. 49:1991;630.
9. Campos L, Guyotat D, Archimbaud E, Calmard-Oriol P, Tsuruo T, Troncy J, Treille D, Fiere D Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood. 79:1992;473.
10. Willman CL Immunophenotyping and cytogenetics in older adults with acute myeloid leukemia: significance of expression of the multidrug resistance gene-1 (MDR1). Leukemia. 10 Suppl 1:1996;S33.
11. Zhou DC, Marie JP, Suberville AM, Zittoun R Relevance of MDR1 gene expression in acute myeloid leukemia and comparison of different diagnostic methods. Leukemia. 6:1992;879.
12. Pall G., Spitaler M., Hofmann J., Thaler J., Ludescher C. Multidrug resistance in acute leukemia: a comparison of different diagnostic methods. Leukemia. 11:1997;1067.
13. Chevillard S, Vielh P, Validire P, Marie JP, Faussat AM, Barbu V, Bayle C, Benard J, Bonnal C, Boutonnat J, Calvo F, Charrier J, Clary A, Colosetti P, Danel-Moore L, Decremoux P, Delvincourt C, Finat-Duclos F, Genne P, Kataki A, Kouyoumdjian JC, Lacave R, Maugard C, Merlin JL, Robert Jet al. French multicentric evaluation of MDR1 gene expression by RT-PCR in leukemia and solid tumors. Standardization of RT-PCR and preliminary comparisons between RT-PCR and immunohostochemistry in solid tumors. Leukemia. 11:1997;1095.
14. Te Boekhorst PA, De Leeuw K, Schoester M, Wittebol S, Nooter K, Hagemeijer A, Lowenberg B, Sonneveld P Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells. Blood. 85:1993;3157.
15. Ota S, Sato T, Kakuda H, Hirano K, Okimoto Y, Mori T, Nakazawa S, Kojima S, Matsuyama T, Tsuruo Tet al. Expression of MDR-1/P-glycoprotein in childhood acute megakaryoblastic leukemia cells. Leuk Lymphoma. 19:1995;431.
16. Chaudhary PM, Roninson LB Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J Natl Cancer Inst. 85:1993;632.
17. Bloomfield CD, Brunning RD Acute leukemia as a terminal event in nonleukemic hematopoietic disorders. Sem Oncol. 3:1976;297.
18. Kuwazuru Y, Yoshimura A, Hanada S, Utsunomiya A, Makino T, Ishibashi K, Kodama M, Iwahashi M, Arima T, Akiyama S Expression of the multidrug transporter, P-glycoprotein, in acute leukemia cells and correlation to clinical drug resistance. Cancer. 66:1990;868.
19. Mitelman F. Catalogue of chromosome abnormalities in cancer. Wiley Liss, New York, 1991.
20. Finiewicz KJ, Anastasi J, Le Beau MM, Arson RA Philadelphia chromosome positive acute myeloid leukemia (AML): phenotypic and cytogenetic heterogeneity. Blood. 88:1996;556a.
21. Vandenberghe E, Martiat P, Banes M, Stul M, Ferrant A, Cuneo A, Cassiman JJ, Mecucci C, van den Berghe H Megakaryoblastic leukemia with an N-ras mutation and late acquisition of a Philadelphia chromosome. Leukemia. 5:1991;683.
22. Melo JV The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood. 88:1996;2375.
23. Westbrook CA, Hoobermann AL, Spino C, Dodge RK, Larson RA, Davey F, Wuster-Hill DH, Sobol RE, Sobol RE, Schiffer C, Bloomfiled CD Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: A cancer and leukemia group B study (8762). Blood. 80:1992;2983.
24. Heisterkamp N, Jenster G, Ten Hoeve J, Zovich D, Pattengale PK, Groffen J Acute leukaemia in BCR/ABL transgenic mice. Nature. 344:1990;251.
25. Martiat P, Mecucci C, Nizet Y, Stul M, Philippe M, Cassiman JJ, Michaux JL, Van den Berghe H, Sokal G P190 BCR/ABL transcript in a case of Philadelphia-positive multiple myeloma. Leukemia. 4:1990;751.
26. Daneshvar-Alavi B, Lutcher C, Welter D Multiple myeloma terminating in acute myelogenous leukemia with the presence of a Philadelphia chromosome. South Med. J 70:1977;1477.
27. Alimena G, Cedrone M, Nanni M, De Cuia MR, Lo Coco F, De Sanctis V, Cimino G, Mancini M Acute leukemia presenting a variant Ph chromosome with p190 expression, dup 3q and -7, developed after malignant lymphoma treated with alkylating agents and topoisomerase II inhibitors. Leukemia. 9:1995;1483.
28. Stockschläder M, Fiedler W, Zander A, Weh HJ, Hossfeld DK Philadelphia chromosome-positive secondary acute leukemia following high-dose chemotherapy with peripheral blood progenitor cell support for relapsed low-grade non-Hodgkin's lymphoma. Ann Hematol. 73:1996;291.